Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Iridex Reports 7 Percent Q2 Revenue Gain
Iridex Reports 7 Percent Q2 Revenue Gain

Iridex (NASDAQ:IRIX), a medical device company specializing in laser-based systems for eye disease treatments, reported its second quarter results on August 12, 2025, covering the three months ended

Webtoon Reports 8 Percent Revenue Gain
Webtoon Reports 8 Percent Revenue Gain

Webtoon Entertainment (NASDAQ:WBTN), a global digital comics publisher and platform operator, reported results on August 12, 2025. Revenue (GAAP) reached $348.3 million, coming in $7.7 million above

Vicarious Surgical Narrows Loss in Q2
Vicarious Surgical Narrows Loss in Q2

Vicarious Surgical (NYSE:RBOT), a developer focused on next-generation robotic technology for minimally invasive surgery, released its second quarter 2025 financial results on August 12, 2025. The

Verrica Posts Profit in Fiscal Q2
Verrica Posts Profit in Fiscal Q2

Verrica Pharmaceuticals (NASDAQ:VRCA), a specialty dermatology company focused on skin disease treatments, released its earnings for the second quarter of fiscal 2025 on August 12, 2025. The

Luminar Posts 5 Percent Sales Drop
Luminar Posts 5 Percent Sales Drop

Luminar Technologies (NASDAQ:LAZR), a leading developer of laser-based sensors and software for advanced driver-assistance systems and autonomous vehicles, reported results for Q2 2025 on August 12

Nexgel Revenue Jumps 100% in Fiscal Q2
Nexgel Revenue Jumps 100% in Fiscal Q2

Nexgel (NASDAQ:NXGL), a maker of hydrogel-based wound care and beauty products, released its second quarter results for fiscal 2025 on August 12, 2025. The key news from the release was strong

Fractyl Health Posts 62% Wider Q2 Loss
Fractyl Health Posts 62% Wider Q2 Loss

Fractyl Health (NASDAQ:GUTS), a clinical-stage biotech developing interventions for obesity and Type 2 Diabetes (T2D), reported its second quarter 2025 results on August 12, 2025. The period was

CXApp Grows ARR and Margins in Q2 2025
CXApp Grows ARR and Margins in Q2 2025

CXApp(NASDAQ:CXAI) reported fiscal Q2 2025 (period ended June 30, 2025) earnings on August 11, 2025, highlighting flat revenue of $1.22 million, gross margin improved to 86%, and significant

Beyond Air XAIR Q1 2026 Earnings Call Transcript
Beyond Air XAIR Q1 2026 Earnings Call Transcript

Image source: The Motley Fool.

Tuesday, August 12, 2025 at 4:30 p.m. ET

Chairman and Chief Executive Officer — Steve Lisi

Continue reading

Source Fool.com

MeridianLink Revenue Jumps 8 Percent
MeridianLink Revenue Jumps 8 Percent

MeridianLink (NYSE:MLNK), a provider of cloud-based software for banks, credit unions, and mortgage lenders, released its second quarter 2025 financial results on August 11, 2025. The company

Ceva Beats Estimates in Fiscal Q2
Ceva Beats Estimates in Fiscal Q2

Ceva (NASDAQ:CEVA), a core supplier of chip design intellectual property (IP) for wireless connectivity and edge artificial intelligence (AI), reported its second quarter 2025 results on August 11

Motorcar Parts Q1 Revenue Up 11 Percent
Motorcar Parts Q1 Revenue Up 11 Percent

Motorcar Parts Of America (NASDAQ:MPAA), a supplier of replacement parts and electrical diagnostic equipment for vehicles, reported its earnings for the fiscal first quarter (ended June 30, 2025) on

Aaon Posts 65 Percent EPS Drop in Q2
Aaon Posts 65 Percent EPS Drop in Q2

Aaon (NASDAQ:AAON), a leading manufacturer of heating, ventilation, and air conditioning (HVAC) equipment, reported earnings for Q2 2025 on August 11, 2025. The results highlighted operational

Village Farms Sales Jump 12 Percent
Village Farms Sales Jump 12 Percent

Village Farms International (NASDAQ:VFF), a diversified greenhouse grower and international cannabis producer, reported GAAP results for Q2 2025 on August 11, 2025. The company posted GAAP earnings

Kymera Revenue Drops 55 Percent in Q2
Kymera Revenue Drops 55 Percent in Q2

Kymera Therapeutics (NASDAQ:KYMR), a biotechnology company recognized for its targeted protein degradation technology, released its second quarter 2025 results on August 11, 2025. The most notable

Intermex Posts Mixed Results in Q2
Intermex Posts Mixed Results in Q2

International Money Express (NASDAQ:IMXI), a leading provider of money transfer services primarily between the United States and Latin America, reported results for Q2 2025 on August 11, 2025. The

Compass Therapeutics Posts Wider Q2 Loss
Compass Therapeutics Posts Wider Q2 Loss

Compass Therapeutics (NASDAQ:CMPX), a clinical-stage biotechnology company focused on developing novel bispecific antibody therapies for cancer, released its second quarter results on August 11

Owens and Minor Misses Fiscal Q2 Targets
Owens and Minor Misses Fiscal Q2 Targets

Owens & Minor (NYSE:OMI), a leading health care logistics and home health product distribution provider, reported its second quarter 2025 earnings on August 11, 2025. The most notable news was the

Why Palantir Stock Soared 21.2% This Week
Why Palantir Stock Soared 21.2% This Week

Shares of Palantir (NASDAQ: PLTR) spiked this week, finishing up 21.2% from last Friday's close. The jump comes as the S&P 500 gained 2.4% and the Nasdaq-100 rose 3.7%. Palantir reported huge

Essent Group Posts $195 Million Profit
Essent Group Posts $195 Million Profit

Essent Group(NYSE:ESNT) reported second-quarter 2025 results on Aug. 8, 2025, with GAAP net income of $195 million, diluted EPS of $1.93, and annualized return on average equity of 14%. Insurance in

Surrozen Reports Q2 Profit on Gains
Surrozen Reports Q2 Profit on Gains

Surrozen (NASDAQ:SRZN), a biotechnology company focused on Wnt pathway modulation in regenerative medicine, delivered its second quarter 2025 earnings on August 8, 2025. The most notable headline

Edesa Biotech Posts Narrower Loss in Q3
Edesa Biotech Posts Narrower Loss in Q3

Edesa Biotech (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory and immune-related diseases, released its fiscal third quarter results on

Atmus Reports Record Sales Growth
Atmus Reports Record Sales Growth

Atmus Filtration Technologies(NYSE:ATMU) reported its second quarter of 2025 results on August 8, 2025, delivering record sales of $454 million (up 4.8% year-over-year), adjusted EBITDA of $95

Essent Group (ESNT) Q2 EPS Beats by 12%
Essent Group (ESNT) Q2 EPS Beats by 12%

Essent Group (NYSE:ESNT), a leading provider of private mortgage insurance and real estate-related insurance, reported results for Q2 2025 on August 8, 2025. The highlight was GAAP earnings per

Plains Gp (PAGP) Q2 Revenue Falls 17%
Plains Gp (PAGP) Q2 Revenue Falls 17%

Plains Gp (NASDAQ:PAGP), a leading midstream energy company operating an expansive network of crude oil and natural gas liquids (NGL) pipelines and storage assets, reported its financial results on